We previously found that tumor-reactive CD8+ T cells primed in lung TdLNs express low levels of Il12rb1 and Il12rb2 (8), and in this report we found that these CD8+ T cells bind IL12-MSA poorly. The gene discussed is IL12RB2; the disease is neoplasm.